We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$112B
AUM Growth
+$936M
Cap. Flow
-$1.26B
Cap. Flow %
-1.13%
Top 10 Hldgs %
31.26%
Holding
4,289
New
46
Increased
1,994
Reduced
1,731
Closed
73

Top Buys

Rank Stock Value
1
EXE
Expand Energy Corp
EXE
+$56.7M
2
APO icon
Apollo Global Management
APO
+$36.8M
3
BA icon
Boeing
BA
+$34.1M
4
WDAY icon
Workday
WDAY
+$31.9M
5
DOCU
DocuSign
DOCU
+$26.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$136M
2
NVDA icon
NVIDIA
NVDA
+$110M
3
MSFT icon
Microsoft
MSFT
+$84.1M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$48.4M
5
XYZ
Block Inc
XYZ
+$44.9M

Sector Composition

Rank Sector Weight
1 Technology 30.97%
2 Financials 13.53%
3 Consumer Discretionary 11.77%
4 Healthcare 10.06%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BZ icon
2776
Kanzhun
BZ
$7.36B
$334K ﹤0.01%
24,185
+2,066
+9% +$30.4K
GNE icon
2777
Genie Energy
GNE
$383M
$333K ﹤0.01%
21,352
-152
-0.7% -$2.38K
TSHA icon
2778
Taysha Gene Therapies
TSHA
$1.89B
$332K ﹤0.01%
192,079
+5,831
+3% +$12.1K
AVAH icon
2779
Aveanna Healthcare
AVAH
$2.07B
$332K ﹤0.01%
72,663
+7,257
+11% +$37.2K
BCAX
2780
Bicara Therapeutics
BCAX
$1.84B
$331K ﹤0.01%
+19,008
New +$396K
NTR icon
2781
Nutrien
NTR
$30.7B
$331K ﹤0.01%
7,398
+247
+3% +$11.7K
ITOS
2782
DELISTED
iTeos Therapeutics
ITOS
$330K ﹤0.01%
43,030
+1,289
+3% +$11.1K
LILA icon
2783
Liberty Latin America Class A
LILA
$1.67B
$330K ﹤0.01%
76,389
-385
-0.5% -$2.11K
TRVI icon
2784
Trevi Therapeutics
TRVI
$2.64B
$329K ﹤0.01%
79,874
-2,097
-3% -$6.71K
VE
2785
DELISTED
VEOLIA ENVIRONNEMENT
VE
$328K ﹤0.01%
23,366
+195
+0.8% +$2.74K
TELN
2786
DELISTED
TELENOR ASA
TELN
$328K ﹤0.01%
29,410
-430
-1% -$4.79K
AVNW icon
2787
Aviat Networks
AVNW
$273M
$328K ﹤0.01%
18,090
+111
+0.6% +$2.03K
DSGN icon
2788
Design Therapeutics
DSGN
$876M
$327K ﹤0.01%
52,932
+2,365
+5% +$13.7K
PCB icon
2789
PCB Bancorp
PCB
$391M
$326K ﹤0.01%
16,114
+131
+0.8% +$2.61K
ASLE icon
2790
AerSale
ASLE
$279M
$325K ﹤0.01%
51,600
+873
+2% +$5K
SVV icon
2791
Savers
SVV
$1.88B
$324K ﹤0.01%
31,572
+586
+2% +$5.82K
ILPT
2792
Industrial Logistics Properties Trust
ILPT
$586M
$323K ﹤0.01%
88,468
-4,000
-4% -$15.4K
LWLG icon
2793
Lightwave Logic
LWLG
$1.25B
$323K ﹤0.01%
153,708
+1,611
+1% +$4.62K
BIDU icon
2794
Baidu
BIDU
$37.2B
$322K ﹤0.01%
3,816
+31
+0.8% +$2.83K
SMLR
2795
DELISTED
Semler Scientific
SMLR
$321K ﹤0.01%
5,952
+83
+1% +$3.81K
KRT icon
2796
Karat Packaging
KRT
$940M
$320K ﹤0.01%
10,580
+156
+1% +$4.51K
CBLL
2797
CeriBell Inc
CBLL
$714M
$320K ﹤0.01%
+12,353
New +$337K
ZBIO
2798
Zenas BioPharma
ZBIO
$2.05B
$319K ﹤0.01%
+38,942
New +$607K
USCB icon
2799
USCB Financial Holdings
USCB
$412M
$318K ﹤0.01%
17,932
+353
+2% +$6.16K
TS icon
2800
Tenaris
TS
$26.8B
$318K ﹤0.01%
8,412
-1,010
-11% -$35.8K

Similar funds

RhumbLine Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, RhumbLine Advisers held 4,289 positions worth $112B, up 0.84% from $111B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 2.8%. RhumbLine Advisers opened 46 new positions and exited 73, leaving the 4,289-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q4 2024 buy was Expand Energy Corp: 614,703 shares worth $61.2M.
  • RhumbLine Advisers added most to Apollo Global Management in Q4 2024, an estimated $36.8M increase.
  • RhumbLine Advisers's biggest Q4 2024 reduction was Apple, cutting an estimated $136M.
  • RhumbLine Advisers fully exited Block Inc in Q4 2024, selling an estimated $44.9M.
  • RhumbLine Advisers's ten largest holdings make up 31% of its $112B portfolio in Q4 2024.
  • RhumbLine Advisers opened 46 new positions and closed 73 in Q4 2024.
  • RhumbLine Advisers's portfolio value rose 0.84% quarter-over-quarter to $112B.

Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.